Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.
Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, Qushmaq I, Meade M, Guyatt G, Geerts W, Walsh MW, Crowther MA, Friedrich JO, Burry L, Bellomo R, Brandão da Silva N, Costa Filho R, Cox MJ, Alves Silva S, Cook DJ; PROTECT (Prophylaxis for Thromboembolism in Critical Care Trial) Investigators.
Pai M, et al. Among authors: friedrich jo.
PLoS One. 2018 Jun 1;13(6):e0198285. doi: 10.1371/journal.pone.0198285. eCollection 2018.
PLoS One. 2018.
PMID: 29856817
Free PMC article.
Clinical Trial.